Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
P 2 (1)

Trial Status

Not Yet Recruiting2
Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07273643Recruiting

Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality

NCT07058025Phase 2Not Yet Recruiting

Mesenchymal Stromal Cell Therapy to Prevent Bronchopulmonary Dysplasia in Extreme Preterm Infants

NCT06737965Not Yet RecruitingPrimary

Cardiovascular Immaturity in Extremely Low Gestational Age Newborns: a Fundamental Prospective Study

Showing all 3 trials

Research Network

Activity Timeline